Eric A. Naioti

Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021

Wesley H. Self, Mark W. Tenforde, Jillian P. Rhoads et al. · MMWR Morbidity and Mortality Weekly Report · 2021 · 455 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +16

Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021

Mark W. Tenforde, Wesley H. Self, Eric A. Naioti et al. · MMWR Morbidity and Mortality Weekly Report · 2021 · 246 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race/ethnicity, NHANES 2005–2014

Jennifer K. Frediani, Eric A. Naioti, Miriam B. Vos et al. · Environmental Health · 2018 · 103 citations · Full text

Veterinary Medicine, Toxicology, Environmental Health +13

Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults — United States, August–December 2021

Mark W. Tenforde, Manish M. Patel, Manjusha Gaglani et al. · MMWR Morbidity and Mortality Weekly Report · 2022 · 99 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021

Nathaniel M. Lewis, Eric A. Naioti, Wesley H. Self et al. · The Journal of Infectious Diseases · 2021 · 23 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17